These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32195031)

  • 1. The HIPPO pathway in gynecological malignancies.
    Wang D; He J; Dong J; Meyer TF; Xu T
    Am J Cancer Res; 2020; 10(2):610-629. PubMed ID: 32195031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo.
    Yang X; Liu Z; Wang X; Tian W; Zhao T; Yang Q; Li W; Yang L; Yang H; Jia Y
    Chem Biol Interact; 2024 Sep; 400():111176. PubMed ID: 39084502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hippo signaling pathway: implications for heart regeneration and disease.
    Del Re DP
    Clin Transl Med; 2014 Dec; 3(1):27. PubMed ID: 26932373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulatory networks of the Hippo signaling pathway in cancer development.
    Wang M; Dai M; Wang D; Xiong W; Zeng Z; Guo C
    J Cancer; 2021; 12(20):6216-6230. PubMed ID: 34539895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo pathway in cell-cell communication: emerging roles in development and regeneration.
    Nita A; Moroishi T
    Inflamm Regen; 2024 Apr; 44(1):18. PubMed ID: 38566194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress on the application of organoids in gynecological tumors.
    Shen Y; Wang Y; Wang SY; Li C; Han FJ
    Front Pharmacol; 2024; 15():1417576. PubMed ID: 38989138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.
    Schiavoni G; Messina B; Scalera S; Memeo L; Colarossi C; Mare M; Blandino G; Ciliberto G; Bon G; Maugeri-Saccà M
    J Transl Med; 2024 May; 22(1):420. PubMed ID: 38702720
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging role of the Hippo pathway in autophagy.
    Wang D; He J; Huang B; Liu S; Zhu H; Xu T
    Cell Death Dis; 2020 Oct; 11(10):880. PubMed ID: 33082313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Hippo-YAP signaling in squamous cell carcinomas.
    Maehama T; Nishio M; Otani J; Mak TW; Suzuki A
    Cancer Sci; 2021 Jan; 112(1):51-60. PubMed ID: 33159406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.
    Dey A; Varelas X; Guan KL
    Nat Rev Drug Discov; 2020 Jul; 19(7):480-494. PubMed ID: 32555376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective.
    Samji P; Rajendran MK; Warrier VP; Ganesh A; Devarajan K
    Cell Signal; 2021 Feb; 78():109858. PubMed ID: 33253912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer.
    Wen X; Wan J; He Q; Wang M; Li S; Jiang M; Qian Z; Liu B; Lu W; Wang K; Gao K; Wan X
    Signal Transduct Target Ther; 2020 May; 5(1):81. PubMed ID: 32457342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of microRNAs in cancer through Hippo signaling pathway.
    Astamal RV; Maghoul A; Taefehshokr S; Bagheri T; Mikaeili E; Derakhshani A; Delashoub M; Taefehshokr N; Isazadeh A; Hajazimian S; Tran A; Baradaran B
    Pathol Res Pract; 2020 Dec; 216(12):153241. PubMed ID: 33065484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management.
    Wang D; Xu T; Zhu H; Dong J; Fu L
    Am J Cancer Res; 2020; 10(12):4017-4037. PubMed ID: 33414983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer.
    Wu Y; Li M; Lin J; Hu C
    Oncol Lett; 2021 Apr; 21(4):313. PubMed ID: 33692845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis.
    Zinatizadeh MR; Miri SR; Zarandi PK; Chalbatani GM; Rapôso C; Mirzaei HR; Akbari ME; Mahmoodzadeh H
    Genes Dis; 2021 Jan; 8(1):48-60. PubMed ID: 33569513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo Signaling Pathway in Drug Resistance in Cancer.
    Zeng R; Dong J
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of Hippo-YAP Signaling with Metabolism.
    Ibar C; Irvine KD
    Dev Cell; 2020 Jul; 54(2):256-267. PubMed ID: 32693058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hippo Pathway as a Driver of Select Human Cancers.
    Kulkarni A; Chang MT; Vissers JHA; Dey A; Harvey KF
    Trends Cancer; 2020 Sep; 6(9):781-796. PubMed ID: 32446746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Methylation and Hydroxymethylation in Cervical Cancer: Diagnosis, Prognosis and Treatment.
    Zhu H; Zhu H; Tian M; Wang D; He J; Xu T
    Front Genet; 2020; 11():347. PubMed ID: 32328088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.